Vanda Pharmaceuticals to Announce Third Quarter 2014 Financial Results on October 27, 2014

WASHINGTON, Oct. 14, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) VNDA, a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the third quarter of 2014 on Monday, October 27, 2014, before the market opens.

The Company will host a conference call at 10:00 AM ET on Monday, October 27, 2014, during which Vanda management will discuss the third quarter 2014 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4540 (domestic) or 1-847-619-6397 (international) and use passcode 38296232.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Monday, October 27, 2014, beginning at 12:30 PM ET and will be accessible until Monday, November 3, 2014, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 38296232.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.